Literature DB >> 21228380

Changes in matrix metalloproteinase network in a spontaneous autoimmune uveitis model.

Florian Hofmaier1, Stefanie M Hauck, Barbara Amann, Roxane L Degroote, Cornelia A Deeg.   

Abstract

PURPOSE: Autoimmune uveitis is a sight-threatening disease in which autoreactive T cells cross the blood-retinal barrier. Molecular mechanisms contributing to the loss of eye immune privilege in this autoimmune disease are not well understood. In this study, the authors investigated the changes in the matrix metalloproteinase network in spontaneous uveitis.
METHODS: Matrix metalloproteinase (MMP) MMP2, MMP9, and MMP14 expression and tissue inhibitor of metalloproteinase (TIMP)-2 and lipocalin 2 (LCN2) expression were analyzed using Western blot quantification. Enzyme activities were examined with zymography. Expression patterns of network candidates were revealed with immunohistochemistry, comparing physiological appearance and changes in a spontaneous recurrent uveitis model.
RESULTS: TIMP2 protein expression was found to be decreased in both the vitreous and the retina of a spontaneous model for autoimmune uveitis (equine recurrent uveitis [ERU]), and TIMP2 activity was significantly reduced in ERU vitreous. Functionally associated MMPs such as MMP2, MMP14, and MMP9 were found to show altered or shifted expression and activity. Although MMP2 decreased in ERU vitreous, MMP9 expression and activity were found to be increased. These changes were reflected by profound changes within uveitic target tissue, where TIMP2, MMP9, and MMP14 decreased in expression, whereas MMP2 displayed a shifted expression pattern. LCN2, a potential stabilizer of MMP9, was found prominently expressed in equine healthy retina and displayed notable changes in expression patterns accompanied by significant upregulation in autoimmune conditions. Invading cells expressed MMP9 and LCN2.
CONCLUSIONS: This study implicates a dysregulation or a change in functional protein-protein interactions in this TIMP2-associated protein network, together with altered expression of functionally related MMPs.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21228380     DOI: 10.1167/iovs.10-6475

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  13 in total

Review 1.  Research progress of stem cells on glaucomatous optic nerve injury.

Authors:  Ya-Sha Zhou; Jian Xu; Jun Peng; Ping Li; Xiao-Juan Wen; Yue Liu; Ke-Zhu Chen; Jia-Qi Liu; Ying Wang; Qing-Hua Peng
Journal:  Int J Ophthalmol       Date:  2016-08-18       Impact factor: 1.779

2.  Precision Medicine: Personalized Proteomics for the Diagnosis and Treatment of Idiopathic Inflammatory Disease.

Authors:  Gabriel Velez; C Nathaniel Roybal; Diana Colgan; Stephen H Tsang; Alexander G Bassuk; Vinit B Mahajan
Journal:  JAMA Ophthalmol       Date:  2016-04       Impact factor: 7.389

3.  Osteopontin and fibronectin levels are decreased in vitreous of autoimmune uveitis and retinal expression of both proteins indicates ECM re-modeling.

Authors:  Cornelia A Deeg; Christina Eberhardt; Florian Hofmaier; Barbara Amann; Stefanie M Hauck
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

4.  Matrix metalloproteinases in the mouse retina: a comparative study of expression patterns and MMP antibodies.

Authors:  Lies De Groef; Lien Andries; Kim Lemmens; Inge Van Hove; Lieve Moons
Journal:  BMC Ophthalmol       Date:  2015-12-29       Impact factor: 2.209

5.  Novel localization of peripherin 2, the photoreceptor-specific retinal degeneration slow protein, in retinal pigment epithelium.

Authors:  Patrizia B Uhl; Barbara Amann; Stefanie M Hauck; Cornelia A Deeg
Journal:  Int J Mol Sci       Date:  2015-01-26       Impact factor: 5.923

6.  Expression of uterine lipocalin 2 and its receptor during early- to mid-pregnancy period in mares.

Authors:  Shingo Haneda; Kentaro Nagaoka; Yasuo Nambo; Masato Kikuchi; Yasuko Nakano; Junyou Li; Motozumi Matsui; Yo-Ichi Miyake; Kazuhiko Imakawa
Journal:  J Reprod Dev       Date:  2016-12-16       Impact factor: 2.214

7.  Therapeutic effect of bone marrow mesenchymal stem cells on laser-induced retinal injury in mice.

Authors:  Yuanfeng Jiang; Yan Zhang; Lingjun Zhang; Meiyan Wang; Xiaomin Zhang; Xiaorong Li
Journal:  Int J Mol Sci       Date:  2014-05-27       Impact factor: 5.923

Review 8.  Matrix Metalloproteinases and Glaucoma Treatment.

Authors:  Robert N Weinreb; Michael R Robinson; Mohammed Dibas; W Daniel Stamer
Journal:  J Ocul Pharmacol Ther       Date:  2020-04-01       Impact factor: 2.671

9.  Retinal endothelial cell phenotypic modifications during experimental autoimmune uveitis: a transcriptomic approach.

Authors:  Deborah A Lipski; Vincent Foucart; Rémi Dewispelaere; Laure E Caspers; Matthieu Defrance; Catherine Bruyns; François Willermain
Journal:  BMC Ophthalmol       Date:  2020-03-17       Impact factor: 2.209

Review 10.  The role of lipocalin-2 in age-related macular degeneration (AMD).

Authors:  Sayan Ghosh; Nadezda Stepicheva; Meysam Yazdankhah; Peng Shang; Alan M Watson; Stacey Hose; Haitao Liu; Joseph Weiss; J Samuel Zigler; Mallika Valapala; Simon C Watkins; Debasish Sinha
Journal:  Cell Mol Life Sci       Date:  2020-01-04       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.